NIH PAR · NIGMS · R35

PAR-27-032: Maximizing Investigators’ Research Award (MIRA) for Early Stage Investigators (ESI)

Reviewed by Dr. Meng ZhaoLast reviewed October 16, 2026Data refreshed October 16, 2026Editorial standards

Open for applicationsExpires Feb 7, 2029

The Maximizing Investigators' Research Award (MIRA) for Early Stage Investigators (ESIs) provides support for ESIs with a program of research that aligns with the NIGMS mission.MIRA distributes funding among promising investigators across the country. The goal is to boost scientific productivity and the chances for important breakthroughs.Through this program, investigators can:Receive independent research funding early to start and sustain strong research careers.Explore new, unique research areas in the NIGMS mission.Take on ambitious, creative projects.Shift focus to include emerging techniques and technologies as needed.Devote more time to mentoring trainees in a stable research…

Full NOFO in the NIH Guide Apply on Grants.gov

NOFO number
PAR-27-032
Type
PAR
Activity code
R35
Primary institute
NIGMS · National Institute of General Medical Sciences
Clinical trials
Optional
Posted
May 12, 2026
Opens
Sep 2, 2026
Expires
Feb 7, 2029

Funded projects

NIH RePORTER lists no awards under PAR-27-032 in FY2022–FY2026. Awards usually appear a few months after the first review cycle.

Participating institutes

2 NIH institutes and offices take applications under PAR-27-032. Contact the program officer at the institute that fits your research before applying.

  • NIGMS · National Institute of General Medical Sciences
  • none

Related notices

NIH lists no related notices for PAR-27-032 yet.

Other open NOFOs for R35

Browse all open NIH NOFOs

About this page

GotGrant gathers the NOFO, its participation and change notices, and its NOSIs from the NIH Guide for Grants and Contracts, and counts funded projects from NIH RePORTER by the opportunity number each award was made under. Data refreshed October 16, 2026; the NIH Guide is the authoritative source. See our data methodology.

Find who wins under this NOFO